Labcorp Holdings
LH
367.13
-1.75
-0.47%
Labcorp Holdings
US · LH
#790 by market cap
Listed 1970
367.13
-1.75
-0.47%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Company notice
LIQUA: SUBSCRIPTION OF 255,000 ORDINARY SHARES OF RM1/- EACH REPRESENTING 51.0% OF THE ISSUED AND PAID-UP CAPITAL OF LH OIL & GAS SDN. BHD. [FORMERLY KNOWN AS BIONAGA SDN. BHD.] ("LH OIL & GAS")Bursa Malaysia · 2004/10/1
-
Company notice
Lianhuan Pharmaceutical Co., Ltd.: notice of approval of LH-1802 glue for drug clinical trialsSZSI · 2021/11/8
-
UBS Maintains Labcorp Holdings(LH.US) With Buy Rating, Maintains Target Price $380Market Newswire · 2026/10/19
-
Company notice
LH GROUP: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026HKEX · 2026/11/3
-
Rating change
A Quick Look at Today's Ratings for Labcorp Holdings(LH.US), With a Forecast Between $380 to $420Market Newswire · 2026/10/29
-
Morgan Stanley Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $388Market Newswire · 2026/10/30
-
Mizuho Securities Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $400Market Newswire · 2026/11/4
-
Rating change
A Quick Look at Today's Ratings for Labcorp Holdings(LH.US), With a Forecast Between $330 to $380Market Newswire · 2026/9/12
-
Rating change
Truist Financial Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $365Market Newswire · 2026/9/21
-
A Quick Look at Today's Ratings for Labcorp Holdings(LH.US), With a Forecast Between $395 to $420Market Newswire · 2026/10/30
-
Mizuho Securities Maintains Labcorp Holdings(LH.US) With Buy Rating, Maintains Target Price $400Market Newswire · 2026/11/17
-
Rating change
Piper Sandler Maintains Labcorp Holdings(LH.US) With Hold Rating, Raises Target Price to $309Market Newswire · 2026/8/4
-
Company notice
Lien Hoe: LIEN HOE CORPORATION BERHAD ("LIENHOE" or "the Company") - PROPOSED DISPOSAL OF LH COMMERCIALS PTE LTD BY LIENHOE TO ISG ASIA LIMITED ("ISG") FOR SGD50,542,616 TO BE SATISFIED BY THE ISSUANCE OF 631,782,701 NEW ISG SHARES OF SGD0.05 EACH AT AN IBursa Malaysia · 2006/4/6
-
Rating change
Evercore Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $340Market Newswire · 2026/9/3
-
Rating change
Barclays Maintains Labcorp Holdings(LH.US) With Hold Rating, Maintains Target Price $330Market Newswire · 2026/10/7
-
Rating change
BofA Securities Initiates Labcorp Holdings(LH.US) With Buy Rating, Announces Target Price $360Market Newswire · 2026/10/16
-
Company notice
Lien Hoe: LIEN HOE CORPORATION BERHAD ("LIENHOE" or "the Company") - PROPOSED DISPOSAL OF LH COMMERCIAL PTE LTD BY LIENHOE TO ISG ASIA LIMITED ("ISG") FOR SGD50,542,616 TO BE SATISFIED BY THE ISSUANCE OF 631,782,701 NEW ISG SHARES OF SGD0.05 EACH AT AN IBursa Malaysia · 2005/6/13
-
Rating change
J.P. Morgan Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $360Market Newswire · 2026/8/3
-
Rating change
J.P. Morgan Maintains Labcorp Holdings(LH.US) With Buy RatingMarket Newswire · 2026/8/26
-
Rating change
Mizuho Securities Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $355Market Newswire · 2026/8/10
-
Rating change
UBS Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $361Market Newswire · 2026/7/31
-
Rating change
BofA Securities Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $320Market Newswire · 2026/7/13
-
Rating change
Truist Financial Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $350Market Newswire · 2026/7/31
-
Rating change
Morgan Stanley Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $338Market Newswire · 2026/7/31
-
Rating change
A Quick Look at Today's Ratings for Labcorp Holdings(LH.US), With a Forecast Between $320 to $360Market Newswire · 2026/7/31
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Labcorp Holdings discussion 0 comments